VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

521 hedge funds and large institutions have $25.8B invested in Vertex Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 85 funds opening new positions, 186 increasing their positions, 185 reducing their positions, and 38 closing their positions.

Holders
521
Holders Change
+38
Holders Change %
+7.87%
% of All Funds
12.99%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.2%
New
85
Increased
186
Reduced
185
Closed
38
Calls
$257M
Puts
$259M
Net Calls
-$2.22M
Net Calls Change
+$3.68M

Top Buyers

1
BlackRock
1
BlackRock
New York
$2.1B
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$1.94B
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$2.51B
4
HM
4
HealthCor Management
New York
$112M
5
Citadel Advisors
5
Citadel Advisors
Florida
$112M

Top Sellers

1
Capital World Investors
1
Capital World Investors
California
$1.96B
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$1.02B
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$2.06B
4
UBS AM
4
UBS AM
Illinois
$149M
5
Thrivent Financial for Lutherans
5
Thrivent Financial for Lutherans
Minnesota
$11.8M
Name Market Value Shares Shares
Change 		Shares
Change %
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$2.51B 22,978,643 +1,118,318 +5%
BlackRock
2
BlackRock
New York
$2.1B 19,246,380 +18,558,874 +2,699%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$2.06B 18,864,648 -1,232,140 -6%
Capital World Investors
4
Capital World Investors
California
$1.96B 17,900,933 -2,857,200 -14%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$1.94B 17,765,933 +2,845,775 +19%
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.8B 16,474,890 +560,796 +4%
State Street
7
State Street
Massachusetts
$1.31B 12,013,178 +239,017 +2%
JPMorgan Chase & Co
8
JPMorgan Chase & Co
New York
$1.02B 9,361,376 -1,235,572 -12%
ClearBridge Investments
9
ClearBridge Investments
New York
$957M 8,754,618 +105,260 +1%
Ameriprise
10
Ameriprise
Minnesota
$901M 8,238,201 -468,434 -5%
Goldman Sachs
11
Goldman Sachs
New York
$400M 3,655,906 -226,338 -6%
WRF
12
Waddell & Reed Financial
Kansas
$397M 3,634,003 -214,602 -6%
Invesco
13
Invesco
Georgia
$321M 2,933,326 +29,887 +1%
Northern Trust
14
Northern Trust
Illinois
$296M 2,705,195 +59,428 +2%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$255M 2,339,821 +191,154 +9%
O
16
OrbiMed
New York
$237M 2,169,200 +9,800 +0.5%
Norges Bank
17
Norges Bank
Norway
$235M 2,151,921 +420,366 +24%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$228M 2,084,233 +5,611 +0.3%
Wells Fargo
19
Wells Fargo
California
$200M 1,832,913 +301,675 +20%
MNA
20
Manning & Napier Advisors
New York
$193M 1,764,419 -361,601 -17%
TCIM
21
TIAA CREF Investment Management
New York
$177M 1,621,013 +321,513 +25%
AAMU
22
Amundi Asset Management US
Massachusetts
$166M 1,518,822 +292,664 +24%
BB
23
BB Biotech
Switzerland
$159M 1,455,445 +40,000 +3%
Jennison Associates
24
Jennison Associates
New York
$156M 1,428,754 +125,744 +10%
UBS AM
25
UBS AM
Illinois
$149M 1,366,764 -869,983 -39%
1
2 3 4 5